Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study. Cheng CY, Chuang WC, Lin CP, Li CH, et al. Cancer Chemother Pharmacol 2025;95:20.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cheng CY, Chuang WC, Lin CP, Li CH, et al. Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study. Cancer Chemother Pharmacol 2025;95:20.
PMID: 39792181